Effect of Intravitreal Ranibizumab in the Treatment of Peripapillary Choroidal Neovascularisation
Joint Authors
Hamoudi, Hassan
Sørensen, Torben Lykke
Source
Issue
Vol. 2011, Issue 2011 (31 Dec. 2011), pp.1-4, 4 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2011-12-22
Country of Publication
Egypt
No. of Pages
4
Main Subjects
Abstract EN
Intravitreal ranibizumab therapy is widely used in treatment of subfoveal choroidal neovascularisation (CNV) in age-related macular degeneration.
We wanted to study the effect of intravitreal ranibizumab therapy in peripapillary CNV.
A prospective recording of treatment outcomes in twelve eyes (12 patients) with peripapillary CNV with intravitreal injections of ranibizumab was performed.
The patients received a series of 3 injections 4–6 weeks apart, and then a new ophthalmic examination was made including OCT and further therapy was given if the peripapillary CNV was still active.
Nine patients had idiopathic peripapillary CNV, and in 3 patients it was associated to age-related macular degeneration.
Followup had to be at least 6 months.
The mean follow-up time was 15.9 (range 9–27) months and the mean number of injections 6.2 (3–10).
In 10 patients treatment had resulted in an inactivation of the peripapillary CNV, but 3 of them had reactivation, while 2 patients had no inactivation.
Currently, 5 patients are continuous to receive treatment.
VA improved in 10 patients.
Intravitreal ranibizumab therapy appears to be effective in patients with peripapillary CNV, but in some cases there is repeated reactivation or continuous activity of the peripapillary CNV.
American Psychological Association (APA)
Hamoudi, Hassan& Sørensen, Torben Lykke. 2011. Effect of Intravitreal Ranibizumab in the Treatment of Peripapillary Choroidal Neovascularisation. Journal of Ophthalmology،Vol. 2011, no. 2011, pp.1-4.
https://search.emarefa.net/detail/BIM-484208
Modern Language Association (MLA)
Hamoudi, Hassan& Sørensen, Torben Lykke. Effect of Intravitreal Ranibizumab in the Treatment of Peripapillary Choroidal Neovascularisation. Journal of Ophthalmology No. 2011 (2011), pp.1-4.
https://search.emarefa.net/detail/BIM-484208
American Medical Association (AMA)
Hamoudi, Hassan& Sørensen, Torben Lykke. Effect of Intravitreal Ranibizumab in the Treatment of Peripapillary Choroidal Neovascularisation. Journal of Ophthalmology. 2011. Vol. 2011, no. 2011, pp.1-4.
https://search.emarefa.net/detail/BIM-484208
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-484208